3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Sarcoma
1
Gynecologic
1
CNS
1
Conditions
Sarcoma
4
Sarcoma, Ewing
3
Osteosarcoma
3
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Liposarcoma
2
Diffuse Intrinsic Pontine Glioma
2
Breast Neoplasms
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma, Kaposi
1
Retinoblastoma
1
Recurrence
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Medulloblastoma
1
Leiomyosarcoma
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Ependymoma
1
Colonic Neoplasms
1
Chondrosarcoma
1
Cholangiocarcinoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cyclophosphamide
39
Peripheral Blood Stem Cell Transplantation
32
fludarabine phosphate
30
Busulfan
26
Filgrastim
24
Cyclosporine
24
Mycophenolic Acid
22
Antilymphocyte Serum
22
Radiotherapy
20
Melphalan
16
Whole-Body Irradiation
15
Tacrolimus
14
Methylprednisolone
14
Methotrexate
13
Cord Blood Stem Cell Transplantation
12
Etoposide
10
sargramostim
5
Thiotepa
5
Temozolomide
5
Sirolimus
5
Rituximab
5
Bevacizumab
5
aldesleukin
4
Therapeutics
4
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Carmustine
4
pembrolizumab
3
Vincristine
3
Topotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
abemaciclib
×
Sarcoma
×
Clear all
NCT02644460
2023-10-26
AflacST1501
Emory University
Phase 1
Completed
53 enrolled